Monthly Archives November 2015

Collaborative lead generation and drug discovery: the European Lead Factory Perspective

A scientific publication released this month in “Drug Discovery Today” (doi:10.1016/j.drudis.2015.09.009) details the results of a benchmark study performed on the screening collection being currently designed and synthesised within the European Lead Factory Consortium. Syncom is a proud partner of the European Lead Factory Consortium. As one of the leading European CRO’s, Syncom has the responsibility, together with academic partners and other SME’s, to develop and synthesise ~200,000 compounds from untapped areas of biologically-relevant chemical space. The European Lead Factory, initiated in 2013, is a 196 € million collaborative venture financed by the Innovative Medicines Initiative (IMI) and is aimed
Read More